Ignite Creation Date:
2024-05-05 @ 10:35 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01143246
Status:
COMPLETED
Last Update Posted:
2022-11-29
First Post:
2010-06-11
Brief Title:
A Placebo-Controlled Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Sponsor:
Mallinckrodt
Organization:
Mallinckrodt
Organization Data
Organization:
Mallinckrodt
Class:
INDUSTRY
Study ID:
IK-4001-HRS-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mallinckrodt
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None